Skip to main content.

Getting Started

Clinical Trial Activation Pathway

  • The study team follows department and school processes to determine study feasibility and gathers required documents.
    • Protocol
    • Informed Consent
    • Budget
    • Contract
    • Manuals
  • The study team submits the Clinical Research Activation Form.
  • The OCTA Portfolio Manager reviews the Clinical Research Activation Form and schedules a kickoff meeting with the study team, to include KUMC and UKHS staff who support study activation.
  • The study team follows up as indicated in the responses to the Clinical Research Activation Form. For clinical trials occurring on the Kansas City campus, this includes (where applicable) the Clinical and Translational Science Unit, Hoglund Imaging Center, Investigational Drug Services and other areas of the University of Kansas Health System.
  • The Portfolio Manager supports timely and efficient activation by assisting to coordinate and harmonize start up activities across the clinical research enterprise. Editorial assistance with informed consents and other documents is available when needed.
  • Parallel study start-up activities proceed, for example:
  • The Portfolio Manager provides written Notice of Activation Approval after confirming completion of required tasks.

Locate your assigned Portfolio Manager and Budget Analysts.

Research Administration

University of Kansas Medical Center
Research Administration
Mailstop 1039
3901 Rainbow Boulevard
Kansas City, KS 66160
Office Location: Support Services Building, Suite 120
Phone: 913-588-1261
Fax: 866-255-2129